• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

Kurt Graves to Replace Ken Frazier in bid to "save" Merck

anonymous

Guest
Stunning news !! Today Merck announced that Ken Frazier will step down so Kurt Graves can once again save Merck. As you should know, sitting in a windowless room, fresh out of the field, Kurt Graves did what no other individual at Merck could accomplish, he single handedly figured out how to navigate the FDA. As you know Merck has floundered every since Kurt left. Today's announcement thrilled Wall Street as Kurt promised to bring Merck the Time2Disrupt philosophy that has guided his work. With the appointment, Merck is expected to become a private company.